The newest litigation against a major pharmacy benefit manager (PBM) comes from a likely source: its small business victims. Read More »
Adding Magnesium To Hydroxychloroquine, Azithromycin and Zinc Treatment Protocols May Offset Cardiac Issues(1,3) Read More »
Eurofins Discovery's mission is to support Pharmaceutical and Biotech companies in their efforts to accelerate drug discovery research and development. Read More »
Vaprisol® safely and effectively addresses hyponatremia in the first 24 hours Read More »
Prespecified analysis of pooled data from ORION-9, -10 and -11 Phase III clinical trials showed inclisiran reduced low-density lipoprotein-cholesterol (LDL-C) by 51% at 17 months Read More »
The American Pharmacists Association (APhA) submitted comments to the Federal Trade Commission (FTC) and the U.S. Department of Justice (DOJ) Antitrust Division addressing the impact vertical mergers are having on the pharmacy supply chain, medication pricing and patient access and choice. Read More »
.jpg){kind=tracking}
As healthcare costs continue to rise in 2020, Valpak, a leader in local print and digital marketing, recently announced a new way to help their customers save on prescription drugs: ValpakRx. Read More »
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biotechnology company specializing in the development of novel treatments for brain tumors, today announced that Anthem Biosciences of Bangalore, India (Anthem) has completed a pilot run of the recrystallization of the Reata Pharmaceuticals, Inc. API (Reata). Read More »
Loopback Analytics, a leading provider of data-driven solutions for hospital and health systems, announced today they are working with UF Health Jacksonville to help advance specialty pharmacy services. Read More »
.jpg){kind=tracking}
e5 Pharma, LLC., today announced the U.S. launch of Diazoxide, USP Oral Suspension, the first generic version of the reference listed drug, Proglycem®. e5 Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) using the Competitive Generic Therapy (CGT) Pathway. Read More »
Nearly 90 percent survival for patients who received REGN-EB3 treatment earlier in the course of their disease; 66.5 percent survival among all patients who received REGN-EB3 Read More »
Bryn's Epinephrine Nasal Spray has Two Doses in One Portable Device Read More »
Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhuGM-CSF), for the potential treatment of Stage IIb-IV melanoma. Read More »
Statement emphasizes the pharmacist's role in educating patients, including the importance of disposing of unused medication Read More »
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced the launch of a generic version of Delzicol®1 (mesalamine) delayed-release capsules, 400 mg, in the U.S. Read More »
AmerisourceBergen issued the following announcement on April 24.Original source can be found here. Read More »
Sunosi is the first and only dual-acting dopamine and norepinephrine reuptake inhibitor approved by the FDA to improve wakefulness in adults living with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea Read More »
The U.S. Food and Drug Administration (FDA) has approved Cablivi®(caplacizumab-yhdp) in combination with plasma exchange and immunosuppression for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in adults. Read More »
Wixela™ Inhub™ is the first FDA-approved therapeutically equivalent generic of ADVAIR DISKUS® (fluticasone propionate and salmeterol inhalation powder) for certain patients with asthma or chronic obstructive pulmonary disease (COPD) Read More »
Alerts Sign-up
